Doxylamine evidence profile
The attached over-the-counter combination label provides product context, while the cited disposition study is in pregnant nonhuman primates.
Doxylamine: evidence and interpretation notes
Why HalfLifeDB does not plot Doxylamine
The attached over-the-counter combination label provides product context, while the cited disposition study is in pregnant nonhuman primates. Those records do not cleanly support a general adult human value for doxylamine on their own.
What each source contributes
- DailyMed: COLD AND FLU DAYTIME, NIGHTTIME, MAXIMUM STRENGTH (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, GUAIFENESIN, PHENYLEPHRINE HCL) KIT [WALGREEN COMPANY]. This product label adds formulation-specific pharmacokinetic context and does not represent every route or product.
- PubChem: Doxylamine. This identity record confirms names and compound identity and does not supply a human half-life.
- Pharmacokinetics of doxylamine given as Bendectin in the pregnant monkey and baboon. This preclinical study documents species-specific disposition or assay work and is not translated into a typical human estimate.
For Doxylamine, the decision to withhold a curve turns on the limits visible in DailyMed: COLD AND FLU DAYTIME, NIGHTTIME, MAXIMUM STRENGTH (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, GUAIFENESIN, PHENYLEPHRINE HCL) KIT [WALGREEN COMPANY]. This product label adds formulation-specific pharmacokinetic context, but it does not represent every route or product.
What evidence would change the page
The publication threshold for a future Doxylamine model is concrete: serial human plasma data, explicit analyte identification, a described route or preparation, and a reported half-life phase. DailyMed: COLD AND FLU DAYTIME, NIGHTTIME, MAXIMUM STRENGTH (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, GUAIFENESIN, PHENYLEPHRINE HCL) KIT [WALGREEN COMPANY] remains useful, but it does not cross that threshold.
InterpretationCategory context and evidence limits
antihistamine context
Antihistamine profiles can show a gap between pharmacokinetic persistence and perceived sedation, alertness, or next-day effects.
- Sedation and anticholinergic effects are not predicted by the curve.
- Age, co-medications, and formulation can change practical interpretation.
- Detection, impairment, and safety questions require context beyond half-life.
EvidenceSource trail and model decision
Sources and evidence context
A linked record is not automatically proof of the displayed value. Study, labeling, review, and compound identity sources serve different purposes; notes below identify limitations when they are known.
- Official labeling DailyMed label: COLD AND FLU DAYTIME, NIGHTTIME, MAXIMUM STRENGTH (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, GUAIFENESIN, PHENYLEPHRINE HCL) KIT [WALGREEN COMPANY].Official U.S. product labeling used for formulation and labeled pharmacokinetic context; its statements apply to the described product.
- Identity record PubChem Compound Summary: Doxylamine.Compound identity and naming record. It supplies chemistry context, not independent numerical support for the model.
- Research abstract PubMed: Pharmacokinetics of doxylamine given as Bendectin in the pregnant monkey and baboon.Non-human primate study; supplemental context only because product labeling and compound records are also linked.
BoundariesWhat this page cannot answer and where to continue
What this page does not answer
- It does not estimate impairment, intoxication, or fitness to drive.
- It does not predict urine, blood, saliva, or hair test results.
- It does not model repeated exposure, tolerance, withdrawal, or interactions.
- It does not replace clinician, pharmacist, toxicologist, or emergency guidance.
Continue with context
- All substance profiles
- Browse the antihistamine group
- Clearance and volume of distribution
- Bioavailability, route, and formulation
- Active metabolites and parent compounds
- First-order vs nonlinear kinetics
- Detection windows vs half-life
- Reading labels and source quality
Read the medical disclaimer, methodology, and research standards before using the model for comparison.